Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients
about
Effect of low dose nicotinic acid on hyperphosphatemia in patients with end stage renal disease.Contemporary management of phosphorus retention in chronic kidney disease: a review.Advances in pharmacotherapy for hyperphosphatemia in renal disease.Pleiotropic effects of niacin: Current possibilities for its clinical use.
P2860
Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Niacin as a drug repositioning ...... anagement in dialysis patients
@ast
Niacin as a drug repositioning ...... anagement in dialysis patients
@en
Niacin as a drug repositioning ...... anagement in dialysis patients
@nl
type
label
Niacin as a drug repositioning ...... anagement in dialysis patients
@ast
Niacin as a drug repositioning ...... anagement in dialysis patients
@en
Niacin as a drug repositioning ...... anagement in dialysis patients
@nl
prefLabel
Niacin as a drug repositioning ...... anagement in dialysis patients
@ast
Niacin as a drug repositioning ...... anagement in dialysis patients
@en
Niacin as a drug repositioning ...... anagement in dialysis patients
@nl
P2860
P3181
P356
P1476
Niacin as a drug repositioning ...... anagement in dialysis patients
@en
P2093
Sooyoung Shin
P2860
P304
P3181
P356
10.2147/TCRM.S71559
P407
P50
P577
2014-10-14T00:00:00Z